CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This research study is studying an immune-based cancer drug as a possible treatment for prostate cancer.The drug involved ...
Phase 2
Boston, Massachusetts, United States and 4 other locations
with the radioligand treatment, 177Lu-PSMA-617, is safe in treating prostate cancer and whether the combination is effective in shr ...
Phase 1
Boston, Massachusetts, United States and 2 other locations
(ADT) in the treatment of metastatic, non-metastatic, and advanced prostate cancers. The first phase of the study is to establish a...
Phase 1, Phase 2
Boston, Massachusetts, United States
used to monitor response to therapy in metastatic hormone sensitive prostate cancer and can be potentially used to optimize future ...
Phase 4
Boston, Massachusetts, United States and 1 other location
androgen deprivation therapy (ADT) with a luteinising hormone releasing hormone analogue (LHRHA) in men having radiation therapy for localised prostate...
Phase 3
Boston, Massachusetts, United States and 92 other locations
of this study is to evaluate the safety, tolerability, and antitumour activity of AZD0754 CAR T-cell therapy in participants with metastatic prostate...
Phase 1, Phase 2
Boston, Massachusetts, United States and 14 other locations
pharmacokinetic (PK), pharmacodynamic (PD), and the preliminary efficacy of JANX007 in adults with metastatic castration-resistant prostate ...
Phase 1
Boston, Massachusetts, United States and 31 other locations
The purpose of this study is to learn whether PYLARIFY PET imaging (study scan) can safely and accurately detect the presence or absence of prostate...
Phase 4
Boston, Massachusetts, United States and 13 other locations
Effects of Saruparib (AZD5305) Alone, Darolutamide Alone, and in Combination Given Prior to Radical Prostatectomy in Men with Newly Diagnosed Prostate...
Phase 1
Providence, Rhode Island, United States and 18 other locations
Cu 64 PSMA I\&T injection for PET/CT imaging in patients with newly diagnosed unfavorable intermediate high-risk, high-risk or very high-risk prostate...
Phase 3
Boston, Massachusetts, United States of America and 42 other locations
Clinical trials
Research sites
Resources
Legal